FDA Evaluates Potential Link Between Bisphosphonate Class And Atrial Fibrillation
This article was originally published in The Pink Sheet Daily
Executive Summary
Recent journal articles on the osteoporosis products’ association with atrial fibrillation spark an “early safety communication" from the agency.